Electromed (NYSE:ELMD) Stock Rating Upgraded by StockNews.com

Electromed (NYSE:ELMD) was upgraded by equities research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued to clients and investors on Tuesday.

Electromed Stock Performance

Shares of ELMD opened at $33.28 on Tuesday. The stock has a market capitalization of $281.55 million, a PE ratio of 46.22 and a beta of 0.33. The company’s 50-day simple moving average is $31.18 and its 200-day simple moving average is $24.61. Electromed has a 1 year low of $10.05 and a 1 year high of $35.56.

Electromed (NYSE:ELMD) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.03 by $0.13. Electromed had a return on equity of 15.32% and a net margin of 11.34%. The company had revenue of $14.67 million for the quarter.

Insider Buying and Selling at Electromed

In related news, Director Andrew Summers sold 12,731 shares of the business’s stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $29.98, for a total value of $381,675.38. Following the transaction, the director now owns 165,755 shares in the company, valued at $4,969,334.90. The trade was a 7.13 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 14.00% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Electromed

Large investors have recently modified their holdings of the stock. Arrowstreet Capital Limited Partnership raised its position in Electromed by 261.0% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 114,579 shares of the company’s stock worth $3,386,000 after buying an additional 82,839 shares during the last quarter. Hunter Associates Investment Management LLC raised its holdings in Electromed by 12.3% during the third quarter. Hunter Associates Investment Management LLC now owns 102,450 shares of the company’s stock worth $2,199,000 after purchasing an additional 11,250 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Electromed in the fourth quarter valued at about $1,760,000. Navellier & Associates Inc. boosted its holdings in Electromed by 228.5% in the 4th quarter. Navellier & Associates Inc. now owns 56,368 shares of the company’s stock valued at $1,666,000 after purchasing an additional 39,208 shares in the last quarter. Finally, Sowell Financial Services LLC acquired a new position in Electromed during the 4th quarter worth approximately $1,518,000. Hedge funds and other institutional investors own 40.82% of the company’s stock.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.